Baker Brothers Advisors - BIOMARIN PHARMACEUTICAL INC ownership

BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 52 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q3 2021$4,611,000
-70.4%
4,500,000
-70.0%
0.02%
-70.6%
Q2 2021$15,566,000
+1.7%
15,000,0000.0%0.07%
+3.0%
Q1 2021$15,299,000
-4.6%
15,000,0000.0%0.07%
+10.0%
Q4 2020$16,033,000
+2.4%
15,000,0000.0%0.06%
-4.8%
Q3 2020$15,650,000
-14.7%
15,000,0000.0%0.06%
-22.2%
Q2 2020$18,340,000
+17.7%
15,000,0000.0%0.08%
-15.6%
Q1 2020$15,576,000
-1.7%
15,000,0000.0%0.10%
+14.3%
Q4 2019$15,841,000
+7.6%
15,000,0000.0%0.08%
-16.0%
Q3 2019$14,722,000
-5.4%
15,000,0000.0%0.10%
-5.7%
Q2 2019$15,566,000
+1.2%
15,000,0000.0%0.11%
+8.2%
Q1 2019$15,385,000
+3.2%
15,000,0000.0%0.10%
-19.7%
Q4 2018$14,911,000
-5.7%
15,000,0000.0%0.12%
+17.3%
Q3 2018$15,818,000
+4.1%
15,000,0000.0%0.10%
-8.8%
Q2 2018$15,198,000
+7.8%
15,000,0000.0%0.11%
-5.0%
Q1 2018$14,099,000
-5.6%
15,000,0000.0%0.12%
-7.0%
Q4 2017$14,928,000
-1.7%
15,000,0000.0%0.13%
+4.9%
Q3 2017$15,193,00015,000,0000.12%
Other shareholders
BIOMARIN PHARMACEUTICAL INC shareholders Q4 2020
NameSharesValueWeighting ↓
Wellesley Asset Management 53,670$57,726,0003.34%
SHENKMAN CAPITAL MANAGEMENT INC 26,959,000$29,149,0003.04%
ADVENT CAPITAL MANAGEMENT /DE/ 84,134,000$90,539,0001.93%
Cheyne Capital Management (UK) LLP 3,220,000$3,452,0001.75%
PFM Health Sciences, LP 40,300,000$43,210,0001.52%
Sonora Investment Management, LLC 6,370,000$6,807,0000.56%
MACKAY SHIELDS LLC 66,018,000$70,980,0000.49%
ZAZOVE ASSOCIATES LLC 1,500,000$1,608,0000.20%
IRON Financial LLC 275,000$295,0000.15%
PALISADE CAPITAL MANAGEMENT, LP 3,000,000$3,216,0000.08%
View complete list of BIOMARIN PHARMACEUTICAL INC shareholders